Prevalence and Risk Factors of Post-Acute Sequela of COVID-19 in Adults with Systemic Autoimmune Rheumatic Diseases

Further Publications Rheumatology

Risk factors of COVID-19 related hospitalization of pediatric patients with rheumatic diseases: a systematic review and meta-analysis

Rheumatology (Oxford)

Zhao Q, Wallace B, Ronis T, Jung L

doi: 10.1093/rheumatology/keae664

Autoimmune DiseaseFurther Publications Rheumatology

Identifying key health system components associated with improved outcomes to inform the re-configuration of services for adults with rare autoimmune rheumatic diseases: a mixed-methods study

Lancet Rheumatol

Hollick RJ, James WRG, Nicoll A, Locock L, Black C, Dhaun N, Egan AC, Fluck N, Laidlaw L, Lanyon PC, Little MA, Luqmani RA, Moir L, McBain M, Basu N

doi: 10.1016/S2665-9913(24)00082-1

Autoimmune Disease

Opioid Use for Adults with and without Systemic Autoimmune/Inflammatory Rheumatic Diseases: Analysis of 2006-2019 United States National Data

Arthritis Care Res (Hoboken)

Huang Y, Bruera S, Agarwal SK, Suarez-Almazor ME, Bazzazzadehgan S, Ramachandran S, Bhattacharya K, Bentley JP, Yang Y

doi: 10.1002/acr.25378

Autoimmune DiseaseFurther Publications Rheumatology

Long-Term Mortality Following SARS-CoV-2 Infection in Rural Versus Urban Dwellers with Autoimmune or Inflammatory Rheumatic Disease (AIRD): A Retrospective Cohort Analysis from the National COVID Cohort Collaborative (N3C)

Arthritis Care Res (Hoboken)

Anzalone AJ, Jackson LE, Singh N, Danila MI, Reisher E, Patel RC, Singh JA, National COVID Cohort Collaborative (N3C) Consortium

doi: 10.1002/acr.25421

Further Publications Immunology

Prevalence and demographics of 331 rare diseases and associated COVID-19-related mortality among 58 million individuals: a nationwide retrospective observational study

Lancet Digit Health

Thygesen JH, Zhang H, Issa H, Wu J, Hama T, Phiho-Gomes AC, Groza T, Khalid S, Lumbers TR, Hocaoglu M, Khunti K, Priedon R, Banerjee A, Pontikos N, Tomlinson C, Torralbo A, Taylor P, Sudlow C, Denaxas S, Hemingway H, Wu H, CVD-COVID-UK/COVID-IMPACT Consortium

doi: 10.1016/S2589-7500(24)00253-X

Further Publications Immunology

Incidence of post-acute COVID-19 symptoms across healthcare settings in seven countries: an international retrospective cohort study using routinely-collected data

EClinicalMedicine

Xie J, López-Güell K, Dedman D, Duarte-Salles T, Kolde R, López-Blasco R, Martínez Á, Mercier G, Abellan A, Arinze JT, Cuccu Z, Delmestri A, Delseny D, Khalid S, Kim C, Kim JW, Kostka K, Loste C, Mateu L, Mayer MA, Meléndez-Cardiel J, Mercadé-Besora N, Mosseveld M, Nishimura A, Nordeng HME, Oyinlola JO, Pérez-Crespo L, Pineda-Moncusí M, Ramírez-Anguita JM, Trinh NTH, Uusküla A, Valdivieso B, Burkard T, Burn E, Català M, Prieto-Alhambra D, Paredes R, Jödicke AM

doi: 10.1016/j.eclinm.2024.102903

Autoimmune Disease

Cost-related Medication Behaviors for Patients with and without Systemic Autoimmune Rheumatic Diseases

Arthritis Care Res (Hoboken)

Yee J, Feldman CH, Oakes EG, Ellrodt J, Guan H, Choi MY, Karlson EW, Costenbader KH

doi: 10.1002/acr.25442

Further Publications ImmunologyFurther Publications Rheumatology

Predictors of Hospitalization in Breakthrough COVID-19 among Fully Vaccinated Individuals with Immune-Mediated Rheumatic Diseases: Data from SAFER-Study

Vaccines (Basel)

Calderaro DC, Valim V, Ferreira GA, Machado KLLL, Ribeiro PDC, Ribeiro SLE, Sartori NS, de Rezende RPV, de Melo AKG, Cruz VA, Vieira ASR, Kakehasi AM, de Landa AT, Burian APN, Peixoto FMMMC, Telles CMPF, do Espírito Santo RC, Baptista KL, de Oliveira YGP, Magalhães VO, de Lima RL, Biegelmeyer E, Lorencini PZ, Teixeira-Carvalho A, Dos Reis-Neto ET, Sato EI, Pinheiro MM, Monticielo OA, de Souza VA, Xavier RM, Pileggi GS, SAFER-Study Group Task Force

doi: 10.3390/vaccines12091031

Juvenile Idiopathic Arthritis

Systemic juvenile idiopathic arthritis and adult-onset Still's disease are the same disease: evidence from systematic reviews and meta-analyses informing the 2023 EULAR/PReS recommendations for the diagnosis and management of Still's disease

Ann Rheum Dis

De Matteis A, Bindoli S, De Benedetti F, Carmona L, Fautrel B, Mitrovic S

doi: 10.1136/ard-2024-225853

Related content

Risk factors of COVID-19 related hospitalization of pediatric patients with rheumatic diseases: a systematic review and meta-analysis

Identifying key health system components associated with improved outcomes to inform the re-configuration of services for adults with rare autoimmune rheumatic diseases: a mixed-methods study

Opioid Use for Adults with and without Systemic Autoimmune/Inflammatory Rheumatic Diseases: Analysis of 2006-2019 United States National Data

Long-Term Mortality Following SARS-CoV-2 Infection in Rural Versus Urban Dwellers with Autoimmune or Inflammatory Rheumatic Disease (AIRD): A Retrospective Cohort Analysis from the National COVID Cohort Collaborative (N3C)

Prevalence and demographics of 331 rare diseases and associated COVID-19-related mortality among 58 million individuals: a nationwide retrospective observational study

Incidence of post-acute COVID-19 symptoms across healthcare settings in seven countries: an international retrospective cohort study using routinely-collected data

Cost-related Medication Behaviors for Patients with and without Systemic Autoimmune Rheumatic Diseases

Predictors of Hospitalization in Breakthrough COVID-19 among Fully Vaccinated Individuals with Immune-Mediated Rheumatic Diseases: Data from SAFER-Study

Systemic juvenile idiopathic arthritis and adult-onset Still's disease are the same disease: evidence from systematic reviews and meta-analyses informing the 2023 EULAR/PReS recommendations for the diagnosis and management of Still's disease